01Impact factor
Impact factor of Acta Materia Medica (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Acta Materia Medica published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is not listed in JCR 2024, so it has no official Journal Impact Factor from Clarivate; the value above is how often its recent papers are cited.
Citations and papers per year
Open access (listed in DOAJ).
02Indexing
Indexing of Acta Materia Medica
| List | Status |
|---|---|
| Science Citation Index Expanded (SCIE) | Not listed |
| Social Sciences Citation Index (SSCI) | Not listed |
| Arts & Humanities Citation Index (AHCI) | Not listed |
| Emerging Sources Citation Index (ESCI) | Not listed |
| Scopus | ✓ Listed |
| Journal Citation Reports 2024 | Not listed |
- Publisher
- Compuscript Ltd
- Scopus source type
- Journal
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
03What it publishes
What Acta Materia Medica publishes: real papers
Words that appear most often in the titles of the papers published here that we track. Choose one to see those papers:
04Published papers
Papers published in Acta Materia Medica
Papers from the publication records ScholarsColab tracks, with their year and citations. Author names are not shown.
- Therapeutic potential of Lonicera japonica Thunb. in inflammation: mechanistic insights from molecular targets20260 citations
- How new drug R&D can solve intractable scientific problems and meet clinical needs: insights from analysis of typical use cases20260 citations
- The multidimensional biology of SKP2: mechanisms, pathologies, and emerging therapeutic frontiers20260 citations
- DT-13 ameliorates LPS-induced acute lung injury via targeting NMMHC IIA to modulate the FOXO1/KLF2/SPHK1 pathway20260 citations
- Network pharmacology-guided discovery of avicularin from Euphorbia humifusa Willd. targeting IL-17 signaling in psoriasis20260 citations
- Gastrointestinal motility disorders: from pathogenesis to therapeutic strategies20260 citations
- From osteoarthritis to rheumatoid arthritis: re-exploring the molecular pathways and therapeutic potential of diacerein20260 citations
- Formulation approaches and strategies for transdermal delivery of insulin: special emphasis on microneedle-based systems20250 citations
- Patient-derived induced pluripotent stem cell organoids for amyotrophic lateral sclerosis drug discovery20250 citations
- Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance20250 citations
- Cryptotanshinone alleviates vasculitis in Kawasaki disease by modulating macrophage-neutrophil interactions20250 citations
- Sarcopenic obesity: prospects of mitochondrial transplantation to combat metabolic deterioration in aging20250 citations
- Application of a macrocyclization strategy in kinase inhibitor development20250 citations
- Arenobufagin suppresses the progression of early-stage hepatocellular carcinoma by inhibiting EpCAM-mediated tumor stemness20250 citations
- Deciphering the regulatory programs of RNA binding proteins in rheumatoid arthritis through single-cell transcriptome analysis20250 citations
- Progress in the structural modification and pharmacological activity of isosteviol20250 citations
- Targeted nanozyme-enabled treatment of cardiovascular diseases20250 citations
- PROTACs improve selectivity for targeted proteins20250 citations
- Euphorbia neriifolia L. extract attenuates heart failure by modulating the Nrf2/ROS/HIF-1α signaling pathway20250 citations
- Coumarin derivatives as inhibitors against monoamine oxidase: Structure-activity relationships and inhibitory mechanisms20250 citations
- Machine learning-powered, high-affinity modification strategies for aptamers20250 citations
- Catapol: a promising natural neuroprotective agent for neurologic disorders20250 citations
- Artificial intelligence in Traditional Chinese Medicine: systematic insights from data mining, large language models, and multimodal fusion20250 citations
- Comparative drug-drug interactions of berberine and astragaloside IV in normal and type 2 diabetes mellitus rats based on UPLC-QqQ-MS/MS20250 citations
- Natural supramolecular photosensitizer with in situ switchable photothermal/photodynamic effects as an imaging platform for precise and controlled cancer …20250 citations
- Exploring food and medicine homology: potential implications for cancer treatment innovations20250 citations
- Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong20250 citations
- Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder20250 citations
- Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus20250 citations
- Discovery of vina-ginsenoside R18 as a novel dual-target inhibitor of dengue virus envelope protein and RNA-dependent RNA polymerase20250 citations
- Discovery of wedelolactone from Eclipta Prostrata (L.) Linn. as a natural PDE4 inhibitor with potent anti-psoriasis effects20250 citations
- Biologically active guanidine alkaloids20250 citations
- Caryota maxima leaf extract extends Caenorhabditis elegans lifespan by inducing mono-unsaturated fatty acid accumulation via DAF-2 signaling20250 citations
- Boosting pancreatic cancer chemotherapy by disrupting nerve–cancer crosstalk20250 citations
- Septin6 as a new approach for AD treatment20240 citations
- Exploring the efficacious subfractions and underlying mechanisms of Herba Siegesbeckiae against myocardial ischemia/reperfusion injury via the UCHL5/NLRP3 …20240 citations
- Preliminary study on Zeqi: from pharmacological action of active ingredients to clinical application research20240 citations
- Brusatol increases chemotherapeutic drug efficacy in pancreatic ductal adenocarcinoma by suppressing Nrf2 signaling20240 citations
- Unlocking the potential of phytosomes: a review of formulation techniques, evaluation methods, and emerging applications20240 citations
- Hepatotoxic effects of aristolochic acid: mechanisms and implications20240 citations
- Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drug20240 citations
- Pristimerin inhibits thioredoxin reductase in the treatment of non-small cell lung cancer20240 citations
- Glyceraldehyde derivatives inspired by empagliflozin as potential anti-heart failure agents independent of glucose-lowering effects20240 citations
- Multi-omics strategy reveals that Cordyceps sinensis ameliorates sepsis-associated acute kidney injury via reprogramming of mitochondrial energy metabolism and …20240 citations
- Bioinformatics-based analysis of fatty acid metabolic reprogramming in hepatocellular carcinoma: cellular heterogeneity, therapeutic targets, and drug discovery20240 citations
- The andrographolide derivative, AND7, AND TRAIL combination attenuates acute lymphoblastic leukemia through P53-regulated ROS accumulation20240 citations
- Identification of GPR35-associated metabolic characteristics through LC-MS/MS-based metabolomics and lipidomics20240 citations
- Development and characterization of temperature-sensitive hydrogels embedded with sodium alginate-chitosan microspheres20240 citations
- High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CL pro20240 citations
- Solving the mysteries of urate transport: structural insights into GLUT9 and URAT120240 citations
- The KIT ligand KITLG promotes portal vein tumor thrombosis by up-regulating COL4A1 through STAT3-SMAD2 signaling in hepatocellular carcinoma20240 citations
- A comparative analysis of vaccine lists, prices, and candidates, and the national immunization program between China and the United States20240 citations
- Macrophage differentiation in enhancing hematopoietic function of ribonucleic acid for injection II via multi-omics analysis20240 citations
- G protein-coupled receptor-biased signaling: potential drug discovery to facilitate treatment of metabolic diseases20240 citations
- Advances in microbial decorations and its applications in drug delivery20230 citations
- Advances in microneedle patches for long-acting contraception20230 citations
- Inhalable ciprofloxacin/polymyxin B dry powders in respiratory infection therapy20230 citations
- ZnPc photosensitizer-loaded peony-shaped FeSe 2 remotely controlled by near-infrared light for antimycobacterial therapy20230 citations
- Potential pharmacokinetic interactions in fixed-dose combinations of perindopril/indapamide/amlodipine compared with perindopril/indapamide and amlodipine in …20230 citations
- Single-cell RNA sequencing reveals the effects of hederasaponin C in the treatment of diabetic nephropathy20230 citations
- STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma20230 citations
- Computational strategies for PROTAC drug discovery20230 citations
- Efficacy of corticosteroids as an adjunctive therapy in the treatment of community-acquired pneumonia: a systematic review and meta-analysis20230 citations
- Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment20230 citations
- Sesquiterpenoids from the sunflower family as potential anti-inflammatory candidates: a review20230 citations
- Animal models of Alzheimer's disease: preclinical insights and challenges20230 citations
- Multi-component Chinese medicine formulas for drug discovery: state of the art and future perspectives20230 citations
- Molecular networking as a natural products discovery strategy20230 citations
- Organoid models for Chinese herbal medicine studies20230 citations
- Recent advances in nano-targeting drug delivery systems for rheumatoid arthritis treatment20230 citations
- Smart stimuli-responsive carrier-free nanoassembly of SN38 prodrug as efficient chemotherapeutic nanomedicine20230 citations
- Phenylethanoid glycoside verbascoside ameliorates podocyte injury of diabetic kidney disease by regulating NR4A1-LKB1-AMPK signaling20230 citations
- Ligands for oral delivery of peptides across the blood-brain-barrier20220 citations
- Research progress in 3D-printed medicinal tablets20220 citations
- Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp220220 citations
- Brusatol modulates diverse cancer hallmarks and signaling pathways as a potential cancer therapeutic20220 citations
- Identification of a cytisine-based EED-EZH2 protein-protein interaction inhibitor preventing metastasis in triple-negative breast cancer cells20220 citations
- Mass spectrometry imaging advances and application in pharmaceutical research20220 citations
- Recent progress in cancer therapy based on the combination of ferroptosis with photodynamic therapy20220 citations
- Effects of β-carotene on glucose metabolism dysfunction in humans and type 2 diabetic rats20220 citations
- Advances in therapeutic nanodrug delivery systems for infectious lung diseases: a review20220 citations
- Protective effects of ginsenoside CK against oxidative stress-induced neuronal damage, assessed with 1H-NMR-based metabolomics20220 citations
- Structurally diverse polydopamine-based nanomedicines for cancer therapy20220 citations
- Small-molecule fluorescence-based probes for aging diagnosis20220 citations
- Prognosis and treatment of complications associated with COVID-19: a systematic review and meta-analysis20220 citations
- Cancer treatment: from traditional Chinese herbal medicine to the liposome delivery system20220 citations
- Factors associated with pharmacists' knowledge regarding high-alert medications: a convenience sample survey in China20220 citations
- The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhibits anticancer activity in gastric cancer20220 citations
05Reviewer comments
Reviewer comments and rejection reasons for Acta Materia Medica
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Acta Materia Medica, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
06Similar journals
Journals similar to Acta Materia Medica
Journals that publish the closest work to the papers above, from the indexing lists:
- Frontiers in PharmacologySCIEScopusJCR 202430 similar papers
- PLoS ONESCIEScopusJCR 202423 similar papers
- PeerJSCIEScopusJCR 20246 similar papers
- Frontiers in Bioengineering and BiotechnologySCIEScopusJCR 202411 similar papers
- Frontiers in ImmunologySCIEScopusJCR 202415 similar papers
- MoleculesSCIEScopusJCR 20245 similar papers
07Journal Finder
Find the right journal for your paper
Is Acta Materia Medica right for your paper? Compare journals
Paste your title, keywords or abstract. We match it against 156,435 published journal papers, by ScholarsColab mentors and other researchers, and show where the closest work appeared, with each journal’s indexing (SCIE, SSCI, AHCI, ESCI, Scopus, JCR 2024).
How it works: no AI or language model is used. Your words are matched against the titles of real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; “not found in our indexing lists” does not prove a journal is unindexed. Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
What is the impact factor of Acta Materia Medica?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Acta Materia Medica is 3.53: papers it published in the two previous years were cited 3.53 times on average in a year. The journal is not listed in JCR 2024, so it has no official Clarivate Journal Impact Factor.
What is the h-index of Acta Materia Medica?
The h-index of Acta Materia Medica is 22 (OpenAlex, October 2026): 22 of its papers have each been cited at least 22 times. Its i10-index is 53.
Is Acta Materia Medica indexed in Scopus?
Yes. Acta Materia Medica appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Acta Materia Medica an SCIE journal?
Acta Materia Medica is not listed in SCIE or the other Web of Science indexes, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Acta Materia Medica in Journal Citation Reports (JCR)?
Acta Materia Medica is not listed in the JCR 2024 list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
What topics does Acta Materia Medica publish?
The papers published in Acta Materia Medica that we track most often mention drug, cancer, delivery, treatment, therapeutic, potential. Check the journal’s aims and scope for its full coverage.
How many papers published in Acta Materia Medica does ScholarsColab track?
We track 88 papers published in Acta Materia Medica between 2022 and 2026, cited 0 times in total, with a median of 0 citations per paper.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Review of Scientific Instruments
- Biochemistry
- Journal of Biological Chemistry
- Science of the Total Environment
- IEEE Access
- Journal of Dairy Science
- Journal of Allergy and Clinical Immunology
- Tetrahedron Letters
- ACS Applied Materials and Interfaces
- Physical Review C
- Annals of Oncology
- Inorganic Chemistry
- Fuel
- Biochemical and Biophysical Research Communications
Browse all journals: indexing, impact factor and reviewer comments →
